Equity · Healthcare
Bristol Myers Squibb (BMY) perpetual futures
BMY perpetual futures on 1 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade BMYUSDT.
Bristol Myers Squibb is a global biopharmaceutical company that researches, develops, and commercializes medicines for diseases including cancer, cardiovascular, immunology, and neurology.
Price chart
Interactive TradingView chart
TradingView symbol NYSE:BMY
Loads TradingView's third-party widget (about 1 MB) on demand.
Trading data
Perpetual market activity
1/1 live markets
Trading data
Perpetual market activity
Spot performance
MEXCTradability
Execution quality
Entry cost and depth per venue at $1k–$100k
Tradability
Execution quality
Entry cost and depth per venue at $1k–$100kNo sufficient depth · 0 of 1 venues absorb $10k
No fresh book data: MEXC
Taker execution estimate incl. approx. fees - maker fills are not guaranteed.
Best venues for this underlying
Best liquidity
BMYTightest spread
BMYHighest volume
BMYFunding history
Stored venue snapshots by market
Funding history
Stored venue snapshots by marketNext catalyst
Catalysts
Next catalyst
Catalysts
No unusual perp activity right now.
Research data
Analysts, filings and peer context
Research data
Analysts, filings and peer context
Estimates
6Company events
6Peer comparison
Similar listed perpsRevenue mix
PendingAnalysts
PendingOwnership
BMY-PERPFilings
PendingTranscripts
PendingCompany news
Reuters, WSJ, Bloomberg and FT first, as far as our news provider delivers them; other publishers behind the second filter. Headlines link to the publisher.No articles from Reuters, WSJ, Bloomberg or FT for this company in our feed.
Company data
Company intelligence
Updated: Nov 2, 2026, 02:50 PM UTC
Company data
Company intelligence
Company profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Chief executive
- Christopher Boerner
- Employees
- 32,500
- IPO date
- Jun 1, 1972
- Country
- US
- Exchange
- New York Stock Exchange
Rating factors
- Return on equityi
- 5
- Return on assetsi
- 5
- Debt to equityi
- 1
- Price to earningsi
- 3
- Price to booki
- 1
Company press releases
Congressional disclosures
Senate
House
Market cap history
Largest fund holders
| Fund | Weight | Shares held |
|---|---|---|
| VTI | 0.17% | 64.8M |
| SCHD | 3.01% | 58.2M |
| VOO | 0.19% | 53.6M |
| IVV | 0.2% | 27.2M |
| 1657.T | 0.15% | 27.2M |
| XSP.TO | 0.19% | 27.2M |
| XWD.TO | 0.14% | 27.2M |
| FXAIX | 0.19% | 26.5M |
| SPY | 0.19% | 24.9M |
| VCPA.S | 0.44% | 21.7M |
| VTV | 0.48% | 19.5M |
| XLV | 1.88% | 14.9M |
Analyst track record
How the analysts covering BMY have done: ratings, price-target accuracy and the measured reaction after their calls.
| 12 months | 3 years | |
|---|---|---|
| Ratings | 209 | 516 |
| Analysts | 26 | 45 |
| Buy / hold / sell | 72 / 124 / 13 | 151 / 324 / 41 |
| Upgrades / downgrades / initiations | 4 / 0 / 3 | 8 / 8 / 8 |
| Price targets hit / missed | 91 / 85 (52%) | 285 / 142 (67%) |
| Avg. return after a rating (TipRanks) | +3.3% | +10.2% |
| Best / worst call | +70.5% / -25.1% | +80.6% / -46.6% |
After buy calls on this stock: median 21-day move +0.1% vs S&P 500 -0.9% (n = 156)
Most accurate on this stock
Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.
- David AmsellemPiper Sandler56% hit rate on this stock · 9 targets measuredBuytarget $78.00Oct 26, 2026
- David RisingerLeerink Partners44% hit rate on this stock · 9 targets measuredHoldtarget $59.00Oct 5, 2026
- Chris SchottJ.P. Morgan36% hit rate on this stock · 11 targets measuredBuytarget $73.00Oct 8, 2026
Latest ratings
| Date | Analyst | Call | Target | |
|---|---|---|---|---|
| Nov 2, 2026 | Courtney BreenBernstein | HoldMaintained | $61.00 | article ↗ |
| Nov 2, 2026 | Courtney BreenBernstein | HoldMaintained | $61.00 | |
| Nov 2, 2026 | Evan SeigermanBMO Capital | HoldMaintained | $60.00 | article ↗ |
| Oct 30, 2026 | Mohit BansalWells Fargo | HoldMaintained | $60.00 | article ↗ |
| Oct 30, 2026 | Mohit BansalWells Fargo | HoldMaintained | $60.00 | article ↗ |
Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.
TipRanks data · computed Nov 3, 2026 · 209 ratings
Frequently asked questions
Where can I trade BMY perpetual futures?
Bristol Myers Squibb (BMY) perpetual futures trade on 1 crypto venues, including MEXC. PerpEquities compares them by live price, funding rate, open interest and liquidity.
Can I trade BMY around the clock?
Yes. Unlike the underlying stock, BMY perpetuals trade 24/7 — including weekends and outside regular market hours.
What is the funding rate on BMY perpetuals?
Right now the BMY perp funding rate is -21.9% annualized (venue median), ranging from -21.9% to -21.9% across 1 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.
How does the BMY perp price compare to the Bristol Myers Squibb stock?
The venue-median BMY perp mark is $64.8 versus a reference stock price of $64.8, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.
What is a BMY perpetual future?
A BMY perpetual is a derivative that tracks the price of Bristol Myers Squibb with no expiry date. It lets you take long or short exposure to Bristol Myers Squibb on crypto venues, around the clock.
What is BMYUSDT perpetual?
BMYUSDT is the symbol most crypto exchanges use for the Bristol Myers Squibb perpetual settled in USDT (Tether). It tracks the BMY share price through an index, trades 24/7 with leverage and never expires.
Embed this asset
<a href="https://perpequities.com/stocks/bmy-perp"><img src="https://perpequities.com/badge/bmy-perp.svg" width="240" height="64" alt="BMY perpetuals · perpequities.com" loading="lazy"></a>